NDC 51662-1263-2 - SOLU-MEDROL
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51662-1263
- Requested NDC
- 51662-1263-2
- Package NDCs from labels
- 51662-1263-1, 51662-1263-2, 51662-1263-3
- Manufacturer
- HF Acquisition Co. LLC, DBA HealthFirst
- Effective date
- 2024-01-29
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| SOLU-MEDROL - HF Acquisition Co. LLC, DBA HealthFirst | HF Acquisition Co. LLC, DBA HealthFirst | 2024-01-29 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 51662-1263-1 | 2020-02-07 | C162847 | 48780-1 | 9d75b9d0-90a6-f424-e053-dadaa90a57ce | SOLU-MEDROL® 125MG PER VIAL 2mL ACT-O-VIAL® |
| 51662-1263-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-90a6-f424-e053-dadaa90a57ce | SOLU-MEDROL® 125MG PER VIAL 2mL ACT-O-VIAL® |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51662-1263-1 | SOLU-MEDROL | 1 mL in 1 VIAL, SINGLE-USE | INJECTION, POWDER, FOR SOLUTION | 1 | 7 | |
| 51662-1263-2 | SOLU-MEDROL | 1 mL in 1 POUCH | INJECTION, POWDER, FOR SOLUTION | 1 | 7 | |
| 51662-1263-3 | SOLU-MEDROL | 25 in 1 CASE | INJECTION, POWDER, FOR SOLUTION | 25 | 7 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51662-1263 | SOLU-MEDROL INJECTION, POWDER, FOR SOLUTION [HF ACQUISITION CO. LLC, DBA HEALTHFIRST] | 7 | Current NDC, Legacy NDC, 3 package rows | 20240131_74e448ed-f4b4-8d09-e053-2991aa0a7500.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| InterSol | PLATELET ADDITIVE 3 | Fenwal, Inc. | a00c4a93-cde2-4753-81f7-0d6fee9fb690 | 2020-10-20 | Warnings, Adverse reactions | GR686LBA74 |
| FREDS SALINE TWIN PACK LAXATIVE | SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM AND SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM | FRED'S | 7d15057f-eb3b-477f-ab14-68c3c38ea910 | 2018-12-26 | Warnings | GR686LBA74 |
| Marcs Twin Pack | SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM AND SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM | Marc Glassman Inc. | 66348ee5-803a-4b78-94dd-55bc9d3543c3 | 2018-07-10 | Warnings | GR686LBA74 |
| QUALITY CHOICE SINGLE SALINE LAXATIVE | SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM AND SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM | Alcyon Health, LLC. | eb499c7f-9c7b-4097-83a3-82aabffd6beb | 2017-07-12 | Warnings | GR686LBA74 |
| Pro-Enema Single Saline Laxative | SODIUM PHOSPHATE, DIBASIC AND SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM | Propharma Medical Supplies | e53c5eda-21da-4aed-a592-315100167cc2 | 2017-06-08 | Warnings | GR686LBA74 |
| Saline Laxative Cherry Laxative | SODIUM PHOSPHATE, DIBASIC AND SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM | Dolgencorp Inc. | ca3c00d9-4301-4de8-94f5-34f1bcc761ab | 2017-04-13 | Warnings | GR686LBA74 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.